The global intramedullary (IM) hip screw market was valued at $1.1 billion in 2024 and is expected to grow at a CAGR of 2.1%, reaching approximately $1.3 billion by 2031.
The IM hip screw market is driven by innovations in material composition, particularly titanium-based devices, which offer enhanced strength and durability. This trend is expected to support steady market growth as demand rises for advanced surgical solutions in hip fracture management.
Market Data Included
- Unit Sales
- Average Selling Prices
- Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts to 2031
- Historical Data to 2024
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Market Trends
Titanium remains the material of choice in the IM hip screw market, owing to its high strength-to-weight ratio, biocompatibility, and corrosion resistance. Companies are increasingly developing next-generation titanium alloys, aiming to further enhance implant longevity and patient outcomes. This focus is expected to lead to a wave of new product introductions over the forecast period.
Market Share Insights (2024)
- 1 Stryker
- Market leader in 2024
- Key product: Gamma(R) Nail, a pivotal device in transitioning the market from traditional hip screws
- Strong brand recognition and technological leadership expected to drive continued market share growth
- 2 DePuy Synthes
- Second-largest market share
- Flagship products: PFNA(R), TFN(R), and TFNA(R) Proximal Femoral Nailing Systems
- Focused on treating proximal femur fractures with titanium-based systems
- Strategic portfolio and innovation support further growth prospects
- 3 Smith & Nephew
- Third-largest competitor
- Key product: TRIGEN INTERTAN(R) Intertrochanteric Antegrade Nail
- Well-established presence in hip fracture treatment
- Expected to maintain market share with continued reliance on established brand equity
Market Segmentation Summary
IM Hip Screw Market - Segmented by Material Type:
Research Scope Summary
- Regions Covered
- North America: United States, Canada
- Latin America: Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela, and others
- Western Europe: France, Germany, U.K., Italy, Spain, Scandinavia, etc.
- Central & Eastern Europe: Russia, Turkey, Poland, Ukraine, Hungary, etc.
- Middle East: Saudi Arabia, UAE, Israel, Qatar, etc.
- Asia-Pacific: China, India, Japan, South Korea, Australia, etc.
- Africa: South Africa, Egypt, Nigeria, Kenya, Morocco, etc.
- Base Year: 2024
- Forecast Period: 2025-2031
- Historical Data: 2021-2024
Quantitative Data
- Market Size & Forecasts
- Market Share
- Units Sold
- Average Selling Prices
- Growth Rates
Qualitative Data
- Growth Trends
- Market Limiters
- Competitive Analysis
- Company Profiles & Product Portfolios
- M&A Activity
- FDA Recalls
- Disruptive Technologies
Data Sources
- Primary Industry Interviews
- Government and Regulatory Databases
- Hospital Procurement Data
- Import/Export Records
- iData Research Internal Database